Left ventricular outflow tract obstruction after transcatheter mitral valve replacement: a case report with a multifaceted approach.

IF 2.8 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Frontiers in Cardiovascular Medicine Pub Date : 2024-08-21 eCollection Date: 2024-01-01 DOI:10.3389/fcvm.2024.1431639
Berenice Caneiro-Queija, Claudio E Guerreiro, Julio Echarte-Morales, Rodrigo Estévez-Loureiro, Manuel Barreiro-Pérez, Rocío González-Ferreiro, Francisco Estévez-Cid, Juan José Legarra, Jose Antonio Baz, Andrés Íñiguez-Romo
{"title":"Left ventricular outflow tract obstruction after transcatheter mitral valve replacement: a case report with a multifaceted approach.","authors":"Berenice Caneiro-Queija, Claudio E Guerreiro, Julio Echarte-Morales, Rodrigo Estévez-Loureiro, Manuel Barreiro-Pérez, Rocío González-Ferreiro, Francisco Estévez-Cid, Juan José Legarra, Jose Antonio Baz, Andrés Íñiguez-Romo","doi":"10.3389/fcvm.2024.1431639","DOIUrl":null,"url":null,"abstract":"<p><p>An 83-year-old woman was admitted to our center because of heart failure. Transthoracic echocardiography revealed severe mitral annular calcification resulting in a double mitral valve lesion. After discussion by the heart team, transcatheter mitral valve replacement with Tendyne (Abbott Structural, Santa Clara, CA, USA) was performed. Despite having a predicted neo-left ventricular outflow tract (LVOT) above the cut-off value, the patient developed clinically significant LVOT obstruction (LVOTO) refractory to medical treatment. This situation is often treated before the intervention, and dealing with LVOTO afterward can be challenging. After taking the patient's anatomy into consideration, we decided to perform alcohol septal ablation. Applying a combined strategy of medical treatment and intervention led to success. In this case report, we discuss this event and the strategies available for preventing and managing the condition.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11371709/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2024.1431639","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

An 83-year-old woman was admitted to our center because of heart failure. Transthoracic echocardiography revealed severe mitral annular calcification resulting in a double mitral valve lesion. After discussion by the heart team, transcatheter mitral valve replacement with Tendyne (Abbott Structural, Santa Clara, CA, USA) was performed. Despite having a predicted neo-left ventricular outflow tract (LVOT) above the cut-off value, the patient developed clinically significant LVOT obstruction (LVOTO) refractory to medical treatment. This situation is often treated before the intervention, and dealing with LVOTO afterward can be challenging. After taking the patient's anatomy into consideration, we decided to perform alcohol septal ablation. Applying a combined strategy of medical treatment and intervention led to success. In this case report, we discuss this event and the strategies available for preventing and managing the condition.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
经导管二尖瓣置换术后的左心室流出道梗阻:采用多元方法的病例报告。
一名 83 岁的妇女因心力衰竭入住本中心。经胸超声心动图显示二尖瓣瓣环严重钙化,导致二尖瓣双瓣病变。经心脏团队讨论后,采用 Tendyne(Abbott Structural,Santa Clara,CA,USA)进行了经导管二尖瓣置换术。尽管预测的新左心室流出道(LVOT)高于临界值,但患者还是出现了药物治疗难治的临床症状明显的左心室流出道梗阻(LVOTO)。这种情况通常会在介入治疗前得到处理,而在介入治疗后处理 LVOTO 可能会很棘手。考虑到患者的解剖结构,我们决定对其进行酒精室间隔消融术。采用药物治疗和介入治疗相结合的策略取得了成功。在本病例报告中,我们将讨论这一事件以及预防和处理该病症的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.80
自引率
11.10%
发文量
3529
审稿时长
14 weeks
期刊介绍: Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers? At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
期刊最新文献
Pediatric RVOT reconstruction with ePTFE trileaflet valved conduits: a dual-center Chinese study First manifestation of cardiovascular disease according to age and sex in a Mediterranean country Outcomes after noncardiac surgery in patients with left ventricular assist devices: a systematic review A comparative study of femoral artery and combined femoral and axillary artery cannulation in veno-arterial extracorporeal membrane oxygenation patients Serum insulin-like growth factor-1 as a potential prognostic biomarker for heart failure with reduced ejection fraction: a meta-analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1